Yuyao Biotechnology

Shanghai, China · Founded 2020 · Privately Held (backing)

Developer of new drugs designed for tumors, neurodegenerative diseases, autoimmune diseases and other diseases. Yuyao Biotechnology is based in Shanghai, China and was founded in 2020. It has raised $90.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$90.3M
Last round
—
Valuation — not yet established

No valuation for Yuyao Biotechnology is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($90.3M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Yuyao Biotechnology with a free account
  • ·Watch Yuyao Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Yuyao Biotechnology funding history

No rounds on record

No funding rounds for Yuyao Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Yuyao Biotechnology's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Yuyao Biotechnology, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Yuyao Biotechnology

How much has Yuyao Biotechnology raised?
Yuyao Biotechnology has raised $90.3M in total funding across its recorded rounds.